AKT1 and neoplasm: All in all, these observations and the above-described timeline of experimental evidence support the notion that, besides SOS1, SOS2 may also constitute a worthy therapy target for prevention and/or treatment of some specific tumor and nontumor pathologies with epidermal origin or dysregulated PI3K/AKT signal transmission [25].